News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
881,211 Results
Type
Article (88638)
Company Profile (817)
Press Release (791725)
Multimedia
Podcasts (230)
Webinars (34)
Section
Business (233530)
Career Advice (4159)
Deals (39956)
Drug Delivery (172)
Drug Development (91633)
Employer Resources (207)
FDA (18532)
Job Trends (17475)
News (398582)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3045)
Academic (2)
Accelerated approval (50)
Adcomms (39)
Allergies (185)
Alliances (56987)
ALS (225)
Alzheimer's disease (1947)
Antibody-drug conjugate (ADC) (503)
Approvals (18824)
Artificial intelligence (822)
Autoimmune disease (321)
Automation (61)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (238)
Biotechnology (487)
Bladder cancer (204)
Brain cancer (81)
Breast cancer (798)
Cancer (6210)
Cardiovascular disease (531)
Career advice (3591)
Career pathing (49)
CAR-T (366)
CDC (75)
Celiac Disease (3)
Cell therapy (1025)
Cervical cancer (49)
Clinical research (78507)
Collaboration (2268)
Company closure (8)
Compensation (1441)
Complete response letters (103)
COVID-19 (3030)
CRISPR (119)
C-suite (1207)
Cystic fibrosis (164)
Data (8118)
Decentralized trials (3)
Denatured (87)
Depression (188)
Dermatology (89)
Diabetes (636)
Diagnostics (7520)
Digital health (61)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (397)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (305)
Earnings (102406)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137714)
Executive appointments (1164)
FDA (22432)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1860)
Gene editing (263)
Generative AI (87)
Gene therapy (832)
GLP-1 (1249)
Government (5546)
Grass and pollen (8)
Guidances (413)
Healthcare (21099)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (347)
Immuno-oncology (105)
Indications (195)
Infectious disease (3405)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (300)
Interviews (820)
IPO (17992)
IRA (61)
Job creations (5206)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (113)
Layoffs (680)
Leadership (50)
Legal (10171)
Liver cancer (108)
Longevity (35)
Lung cancer (811)
Lymphoma (440)
Machine learning (64)
Management (66)
Manufacturing (1157)
MASH (206)
Medical device (15235)
Medtech (15363)
Mergers & acquisitions (23223)
Metabolic disorders (1699)
mRNA (249)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (474)
Neuropsychiatric disorders (125)
Neuroscience (3602)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5137)
Now hiring (79)
Obesity (823)
Opinion (368)
Ovarian cancer (229)
Pain (275)
Pancreatic cancer (316)
Parkinson's disease (390)
Partnered (39)
Patents (627)
Patient recruitment (702)
Peanut (67)
People (67781)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24260)
Phase 2 (34102)
Phase 3 (25647)
Pipeline (8998)
Policy (388)
Postmarket research (3559)
Preclinical (10926)
Press Release (72)
Prostate cancer (321)
Psychedelics (68)
Radiopharmaceuticals (355)
Rare diseases (1206)
Real estate (7458)
Recruiting (81)
Regulatory (30126)
Reports (77)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (27)
RSV (98)
Schizophrenia (191)
Series A (315)
Series B (228)
Service/supplier (30)
Sickle cell disease (122)
Special edition (31)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4365)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (140)
Vaccines (1267)
Venture capital (124)
Weight loss (568)
Women's health (132)
Worklife (24)
Date
Today (102)
Last 7 days (883)
Last 30 days (3655)
Last 365 days (32962)
2026 (13560)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (391)
Arkansas (16)
Asia (52106)
Australia (9166)
California (13844)
Canada (3884)
China (1456)
Colorado (596)
Connecticut (614)
Delaware (427)
Europe (120147)
Florida (2049)
Georgia (451)
Hawaii (4)
Idaho (69)
Illinois (1179)
India (99)
Indiana (640)
Iowa (25)
Japan (558)
Kansas (141)
Kentucky (56)
Louisiana (46)
Maine (89)
Maryland (1690)
Massachusetts (10108)
Michigan (414)
Minnesota (770)
Mississippi (7)
Missouri (161)
Montana (37)
Nebraska (30)
Nevada (149)
New Hampshire (92)
New Jersey (3687)
New Mexico (34)
New York (3634)
North Carolina (1876)
North Dakota (11)
Northern California (6837)
Ohio (430)
Oklahoma (26)
Oregon (55)
Pennsylvania (2751)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5418)
Tennessee (218)
Texas (2246)
United States (49589)
Utah (413)
Vermont (1)
Virginia (359)
Washington D.C. (88)
Washington State (1142)
West Virginia (4)
Wisconsin (153)
Wyoming (2)
There are 881,211 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.
May 18, 2026
·
1 min read
·
Tristan Manalac
Postmarket research
Amgen’s rare disease drug Tavneos tied to 20 deaths in Japan
The FDA has previously linked eight deaths in the U.S. to Tavneos and has alleged that doctored data were used to support the drug application that led to its approval in 2021.
May 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 18, 2026
·
11 min read
Press Releases
Zenflow Presents the BREEZE™ Pivotal Clinical Trial at the American Urological Association Annual Meeting
May 18, 2026
·
5 min read
Press Releases
Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial
May 18, 2026
·
3 min read
Press Releases
ImmunityBio Announces Comprehensive U.S. Patents Covering Combination of ANKTIVA with BCG for Cancer Treatment, with Terms Through 2035
May 18, 2026
·
10 min read
Press Releases
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer
May 18, 2026
·
3 min read
Press Releases
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System
May 18, 2026
·
3 min read
Press Releases
Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support
May 18, 2026
·
16 min read
Press Releases
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
May 18, 2026
·
16 min read
1 of 88,122
Next
